• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Vancomycin resistance in the enterococcus. Relevance in pediatrics.

作者信息

Rice L B, Shlaes D M

机构信息

Infectious Diseases Section, Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA.

出版信息

Pediatr Clin North Am. 1995 Jun;42(3):601-18. doi: 10.1016/s0031-3955(16)38981-7.

DOI:10.1016/s0031-3955(16)38981-7
PMID:7761143
Abstract

Enterococci are nosocomial pathogens intrinsically resistant to a variety of commonly used antimicrobial agents. The frequent use of antimicrobial agents such as cephalosporins has been associated with the increased isolation of enterococci in pediatric hospitals. In addition to their intrinsic resistance traits, the enterococci have rapidly accumulated a variety of acquired resistance determinants. Strains that are resistant to all currently available antibiotics are now being isolated from infected children. The threat of untreatable enterococcal infection and the possibility that vancomycin resistance may spread from the enterococci to the more virulent pneumococci or staphylococci argue for vigilant surveillance for resistant strains, isolation and barrier precautions for infected patients, increased research into the mechanisms of resistance, and a reinvigorated effort to identify new classes of antimicrobial agents.

摘要

相似文献

1
Vancomycin resistance in the enterococcus. Relevance in pediatrics.
Pediatr Clin North Am. 1995 Jun;42(3):601-18. doi: 10.1016/s0031-3955(16)38981-7.
2
Vancomycin-resistant enterococci.耐万古霉素肠球菌
Clin Infect Dis. 1998 May;26(5):1196-9. doi: 10.1086/520283.
3
Vancomycin-resistant enterococci. Mechanism and clinical relevance.耐万古霉素肠球菌。作用机制及临床意义。
Infect Dis Clin North Am. 1997 Dec;11(4):851-65. doi: 10.1016/s0891-5520(05)70393-7.
4
Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities.耐甲氧西林金黄色葡萄球菌和耐万古霉素肠球菌:治疗现状与前景
Lancet. 1997 Jun 28;349(9069):1901-6. doi: 10.1016/s0140-6736(96)11192-2.
5
Optimizing therapy for vancomycin-resistant enterococci (VRE).优化耐万古霉素肠球菌(VRE)的治疗方法。
Semin Respir Crit Care Med. 2007 Dec;28(6):632-45. doi: 10.1055/s-2007-996410.
6
Multidrug-resistant enterococci: a threat to the surgical patient.多重耐药肠球菌:对外科手术患者的一种威胁。
Am J Surg. 1995 May;169(5A Suppl):8S-12S.
7
Enterococcal resistance--an overview.肠球菌耐药性——概述
Indian J Med Microbiol. 2005 Oct;23(4):214-9.
8
Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.多重耐药革兰氏阳性病原体。当前微生物学模式的最新情况。
Drugs. 1997;54 Suppl 6:11-20. doi: 10.2165/00003495-199700546-00005.
9
Nosocomial enterococci resistant to vancomycin--United States, 1989-1993.1989 - 1993年美国医院内耐万古霉素肠球菌
MMWR Morb Mortal Wkly Rep. 1993 Aug 6;42(30):597-9.
10
Reducing the spread of antimicrobial-resistant microorganisms. Control of vancomycin-resistant enterococci.减少抗菌药物耐药微生物的传播。耐万古霉素肠球菌的控制。
Pediatr Clin North Am. 1995 Jun;42(3):703-16. doi: 10.1016/s0031-3955(16)38986-6.

引用本文的文献

1
Antibacterial resistance.抗菌耐药性
Indian J Pediatr. 2004 Mar;71(3):229-39. doi: 10.1007/BF02724275.
2
Molecular epidemiology of vancomycin-resistant Enterococcus faecium in a large urban hospital over a 5-year period.一家大型城市医院5年间耐万古霉素屎肠球菌的分子流行病学研究
J Clin Microbiol. 1999 Dec;37(12):3912-6. doi: 10.1128/JCM.37.12.3912-3916.1999.
3
Vancomycin-resistant Enterococcus faecium colonization in children.儿童耐万古霉素屎肠球菌定植
J Clin Microbiol. 1999 Feb;37(2):413-6. doi: 10.1128/JCM.37.2.413-416.1999.
4
Activity of HMR 3647 compared to those of six compounds against 235 strains of Enterococcus faecalis.与六种化合物相比,HMR 3647对235株粪肠球菌的活性。
Antimicrob Agents Chemother. 1999 Jan;43(1):166-8. doi: 10.1128/AAC.43.1.166.
5
Activities and time-kill studies of selected penicillins, beta-lactamase inhibitor combinations, and glycopeptides against Enterococcus faecalis.所选青霉素、β-内酰胺酶抑制剂组合及糖肽类药物对粪肠球菌的活性及杀菌时间研究
Antimicrob Agents Chemother. 1998 Apr;42(4):857-61. doi: 10.1128/AAC.42.4.857.
6
Rapid increase in the prevalence of antimicrobial drug resistance among enterococcal blood isolates in southern Israel.以色列南部肠球菌血流分离株中抗菌药物耐药性患病率迅速上升。
Eur J Clin Microbiol Infect Dis. 1997 Dec;16(12):913-5. doi: 10.1007/BF01700558.